FILE PHOTO: The logo of Nvidia Corporation is seen during the annual Computex computer exhibition in Taipei JERUSALEM (Reuters) - Israel's CytoReason, which uses AI to develop disease models, said on ...
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. CHICAGO — Funding cancer research isn't usually a ...
As the researchers behind Pfizer and Astellas' Padcev and Merck's Keytruda have taken victory laps on the heels of the ...
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy ...
The National Comprehensive Cancer Network Oncology Research Program, in collaboration with Pfizer Independent Grants for Learning & Change, has awarded six independent grants to healthcare ...
JERUSALEM (Reuters) - Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round. Nvidia, Pfizer, Thermo Fisher and venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback